×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ABT – abbott laboratories (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ABT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
6/2
04:25 pm
abt
Blood Screening Market Research | 2023-2030 [MarketWatch]
Low
Report
Blood Screening Market Research | 2023-2030 [MarketWatch]
6/2
12:20 pm
abt
Biotech Networks Extends its Reach to Twelve US Life Science Hubs and Announces 2023-2024 Scientific Speed Networking Event Tour
Low
Report
Biotech Networks Extends its Reach to Twelve US Life Science Hubs and Announces 2023-2024 Scientific Speed Networking Event Tour
5/31
11:54 am
abt
Abbott accuses one of its former scientists of trade-secrets theft in US court [Reuters]
Low
Report
Abbott accuses one of its former scientists of trade-secrets theft in US court [Reuters]
5/31
09:00 am
abt
Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign
Low
Report
Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign
5/30
07:42 am
abt
Abbott Laboratories (NYSE: ABT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $112.00 price target on the stock.
Low
Report
Abbott Laboratories (NYSE: ABT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $112.00 price target on the stock.
5/29
04:03 am
abt
Immunoassay Instruments Market Research | 2023-2030 [MarketWatch]
Low
Report
Immunoassay Instruments Market Research | 2023-2030 [MarketWatch]
5/25
04:01 pm
abt
Abbott Laboratories: Organic Growth Will Carry It Through [Seeking Alpha]
Low
Report
Abbott Laboratories: Organic Growth Will Carry It Through [Seeking Alpha]
5/25
12:44 am
abt
2030, Pediatric Epilepsy Therapeutics Market: Trend & Outlook [MarketWatch]
Low
Report
2030, Pediatric Epilepsy Therapeutics Market: Trend & Outlook [MarketWatch]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
5/4
04:05 pm
abt
Form 10-Q ABBOTT LABORATORIES For: Mar 31
Low
Report
Form 10-Q ABBOTT LABORATORIES For: Mar 31
5/3
07:10 pm
abt
Form 4 ABBOTT LABORATORIES For: May 02 Filed by: Wainer Andrea F
Low
Report
Form 4 ABBOTT LABORATORIES For: May 02 Filed by: Wainer Andrea F
5/2
08:08 pm
abt
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: Stratton John G
Low
Report
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: Stratton John G
5/2
08:05 pm
abt
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: STARKS DANIEL J
Low
Report
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: STARKS DANIEL J
5/2
08:03 pm
abt
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: Roman Michael F
Low
Report
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: Roman Michael F
5/2
07:59 pm
abt
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: O'Grady Michael
Low
Report
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: O'Grady Michael
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Abbott Labs Is Sliding Closer To Attractive Territory [Seeking Alpha]
10.0%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
3/16 Form 4 ABBOTT LABORATORIES For: Mar 13 Filed by: Boudreau Philip P 6.6%
3/27 Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes 6.4%
4/16 Form 8-K ABBOTT LABORATORIES For: Apr 16 5.6%
3/1 The Best Dividend Aristocrat You Can Buy Right Now [The Motley Fool] 5.4%
3/3 Form 4 ABBOTT LABORATORIES For: Feb 28 Filed by: Wainer Andrea F 5.2%
3/9 Form 3 ABBOTT LABORATORIES For: Mar 01 Filed by: Boudreau Philip P 5.0%
4/8 Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic 4.7%
4/13 Fed Circuit orders new trial in Abbott drug test patent case [Reuters] 4.2%
4/3 UPDATE 2-Anyone near Trump or Pence will be given rapid coronavirus test - White House [Reuters] 4.1%
TOP News Decliners
3/18
Associated Press: Cancer and heart surgeries now delayed as coronavirus alters care [MarketWatch]
-10.8%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
3/13 Form DEF 14A ABBOTT LABORATORIES For: Apr 24 -10.6%
3/22 You Won't Regret Buying These 3 Bargain Stocks [The Motley Fool] -9.8%
3/19 Africa coronavirus cases to rise as some undetected - Africa's CDC [Reuters] -8.7%
2/3 Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke -5.4%
2/25 The Real Earnings Season Starts Now: Time To Read The Footnotes [Forbes] -4.4%
3/27 Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Morgan Stanley from $101.00 to $96.00. They now have an "overweight" rating on the stock. -3.7%
3/31 Phase 4 Coronavirus Infrastructure Spending To Start At $2 Trillion [Forbes] -3.7%
8/13 Form 4 ABBOTT LABORATORIES For: Aug 09 Filed by: Funck Robert E -3.5%
3/10 Form 4 ABBOTT LABORATORIES For: Mar 06 Filed by: Watkin Jared -3.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: